Search results
W uwzględnionych badaniach porównano stosowanie remdesiwiru wraz ze standardową opieką zdrowotną lub standardową opieką zdrowotną (z placebo lub bez niego) u hospitalizowanych chorych na COVID-19. Pacjenci hospitalizowani z umiarkowanym lub ciężkim przebiegiem COVID-19.
- English
• For adults hospitalised with COVID-19, remdesivir probably...
- Bahasa Malaysia
Tiada kajian menilai orang tanpa gejala COVID-19. Purata...
- Deutsch
In keiner Studie wurden Personen mit symptomloser...
- Remdesivir
中度至重度 covid-19 的住院患者. 瑞德西韋可能對 28 天、60 天後的死亡或 150...
- English
Patients with mild-to-moderate disease who are at high risk for progression to severe COVID-19 . Treatment with remdesivir for three days in ambulatory patients reduced hospitalizations and COVID-19-related medically attended visits throughout day 28 (HR: 0.28; 95% CI: 0.1, 0.75, low CoE; and HR: 0.19; 95% CI: 0.07, 0.56, low CoE, respectively).
Treatment Locator. Find COVID-19 Medications. The map below displays pharmacies, clinics, and other locations with safe and effective COVID-19 medications. These medications require a prescription from a healthcare provider.
11 maj 2022 · If you've just tested positive for COVID-19, and you have common risk factors for serious illness, there are now ample treatments available – generally at little or no cost – that could help...
Find a pharmacy near you to pick up PAXLOVID™ (nirmatrelvir tablets; ritonavir tablets) for COVID-19 treatment. See risks, benefits and BOXED WARNINGS.
22 kwi 2022 · Today, WHO made a strong recommendation for nirmatrelvir and ritonavir, sold under the name Paxlovid, for mild and moderate COVID-19 patients at highest risk of hospital admission, calling it the best therapeutic choice for high-risk patients to date.
Walgreens pharmacists can now prescribe Paxlovid to help treat COVID-19. Learn more today and see if you are eligible for the antiviral treatment.